Reports
Reports
Sale
The global infection prevention devices market size was valued at USD 19.31 billion in 2023, driven by the rising need to prevent rather than cure diseases due to the increasing health care costs. The market is anticipated to grow at a CAGR of 5.5% during the forecast period 2024-2032 to reach a value of USD 31.26 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is the leading market for infection prevention devices due to the growing demand for infection prevention because of the rising surgery rates and patient admissions. The European infection prevention devices market is also expected to grow in the coming years due to the rising geriatric population in the region. With the increasing investments in the industry in countries like China, the industry in the Asia Pacific region is expected to grow at a robust rate in the forecast period.
Infection prevention devices are equipment or services that help prevent the occurrence of diseases, especially among the at-risk population, like geriatrics, people who have undergone surgeries, or people with a weak immune system.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The infection prevention devices market can be broadly categorised based on its products into:
Based on end-uses, the industry can be divided into:
The EMR report looks into the regional markets of infection prevention devices like North America, Europe, Latin America, the Asia Pacific, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is being driven by the rising need to prevent rather than cure diseases due to the increasing health care costs. The growing resistance to antibiotics and the slow development of new antibiotics is expected to propel the growth of the industry further. The industry is also supported by the growing rates of hospital admission and outpatient visits.
Infection prevention supplies is expected to be the largest product segment in the market. Based on end-use, hospitals are the largest end-use segment in the industry due to the rising admittance of the geriatric population and the growing research on old age-related diseases.
The report presents a detailed analysis of the following key players in the global infection prevention devices market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Infection Prevention Devices Market Overview
3.1 Global Infection Prevention Devices Market Historical Value (2017-2023)
3.2 Global Infection Prevention Devices Market Forecast Value (2024-2032)
4 Global Infection Prevention Devices Market Landscape
4.1 Global Infection Prevention Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Infection Prevention Devices Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by End User
5 Global Infection Prevention Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Infection Prevention Devices Market Segmentation
6.1 Global Infection Prevention Devices Market by Product
6.1.1 Market Overview
6.1.2 Infection Prevention Supplies
6.1.3 Infection Prevention Services
6.1.4 Infection Prevention Equipment
6.2 Global Infection Prevention Devices Market by End User
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Lifescience Industries
6.2.4 Clinical Laboratories
6.2.5 Others
6.3 Global Infection Prevention Devices Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Infection Prevention Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Infection Prevention Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Infection Prevention Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Infection Prevention Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Infection Prevention Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Medline Industries, LP
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Cardinal Health
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Paul Hartmann AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Mölnlycke Health Care AB
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 3M Company
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 B. Braun Melsungen AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Coloplast Group
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Becton, Dickinson and Company
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Hollister Incorporated
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Medical Devices Business Services, Inc. (Johnson & Johnson)
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Getinge AB
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 ANSELL LTD
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 BD
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Infection Prevention Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global infection prevention devices market reached a value of USD 19.31 billion in 2023.
The market is projected to grow at a CAGR of 5.5% during the forecast period of 2024-2032 to reach a value of USD 31.26 billion by 2032.
The increasing incidences of hospital-acquired infections and the rising geriatric population are the major factors driving the growth of this market.
The key trends of the market include rapid advancements in technology, expanding healthcare infrastructure, and the rising personal safety awareness.
The major regions in the infection prevention devices market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Infection prevention supplies, infection prevention services, and infection prevention equipment are the different products in the market.
Hospitals, lifescience industries, and clinical laboratories, among others, are the various end uses of infection prevention devices in the market.
Infection prevention devices refer to the disposables, consumables, and medical devices that are designed to aid in the prevention or control of infections.
Infections can be spread by the use of infected needles or syringes, unprotected sexual contact, and animal or insect bites.
At-risk populations including people with weakened immune systems, geriatrics, and post-surgery patients are recommended the use of infection prevention devices.
The key players in the global infection prevention devices market are Medline Industries, LP, Cardinal Health, Paul Hartmann AG, Mölnlycke Health Care AB, The 3M Company, B. Braun Melsungen AG, Coloplast Group, Becton, Dickinson and Company, Hollister Incorporated, and Medical Devices Business Services, Inc. (Johnson & Johnson), among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.